Scientific Publications

 

 

i

Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial

Paxton Loke, Francesca Orsini, Adriana C Lozinsky, Michael Gold, Michael D O’Sullivan, Patrick Quinn, Melanie Lloyd, Sarah E Ashley, Sigrid Pitkin, Christine Axelrad, Jessica R Metcalfe, Ee Lyn Su, Dean Tey, Marnie N Robinson, Katrina J Allen, Susan L Prescott, Audrey Dunn Galvin, Mimi L K Tang, PPOIT-003 study group*

i

Supplementary Appendix - The Lancet Child & Adolescent Health

i

Administration of a probiotic with peanut oral immunotherapy: A randomized trial

Tang et al, J Allergy Clin Immunol 2015;135:737-44

i

The longitudinal impact of probiotic and peanut oral immunotherapy on health‐related quality of life

Dunn Galvin et al, 2017;00:1–9

i

Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial

Hsiao et al, Lancet Child Adolesc Health 2017; 1: 97–105